The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:The Centre of Excellence for Prevention of Organ Failure - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10290
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in transplantation, chronic kidney disease, and others. It offers services such as chronic obstructive pulmonary disease, chronic heart failure, acute heart failure, recovered organ failure, and others. PROOF Centre provides blood-based biomarker tests for the prevention, diagnosis and treatment of heart, lung and kidney failure, among others. The center caters its clients across Canada. PROOF Centre is headquartered in Vancouver, British Columbia, Canada.

The Centre of Excellence for Prevention of Organ Failure – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deal Details 10
Partnerships 10
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure – Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure – Key Employees 18
The Centre of Excellence for Prevention of Organ Failure – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Key Facts 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure, Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure, Key Employees 18

List of Figures
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …
  • Berkshire Hathaway Inc:戦略・SWOT・企業財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Karnataka Power Corporation Ltd:企業の戦略的SWOT分析
    Karnataka Power Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • KIYATEC Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary KIYATEC Inc (KIYATEC) is a biotechnology company that commercializes 3D cell culture technology. The company concentrates on data correlation to human clinical outcomes. It provides drug response profiling services for developing small molecule compounds and biologic drugs. KIYATEC offers cu …
  • Teijin Pharma Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Teijin Pharma Ltd (Teijin Pharma), a subsidiary of Teijin Ltd develops, manufactures and markets pharmaceutical and home healthcare products. The company offers a range of pharmaceutical products for the treatment of bone and joint diseases, respiratory diseases and cardiovascular and metabo …
  • Bristol-Myers Squibb Co (BMY)-医療機器分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • Takeda Pharmaceuticals USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • Nachi-Fujikoshi Corp.
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lampsa Hotel Company:企業の戦略・SWOT・財務分析
    Lampsa Hotel Company - Strategy, SWOT and Corporate Finance Report Summary Lampsa Hotel Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ClubCorp Holdings Inc:企業のM&A・事業提携・投資動向
    ClubCorp Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ClubCorp Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Febo Beheer BV:企業の戦略・SWOT・財務情報
    Febo Beheer BV - Strategy, SWOT and Corporate Finance Report Summary Febo Beheer BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • City Utilities of Springfield:発電所・企業SWOT分析
    City Utilities of Springfield - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Valid Solucoes SA (VLID3):企業の財務・戦略的SWOT分析
    Valid Solucoes SA (VLID3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Geisinger:医療機器:M&Aディール及び事業提携情報
    Summary Geisinger formerly, Geisinger Health System is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers medical services for patients related to cardiology, ENT, gastroenterology, gynecology, cancer, …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cobham plc:企業のM&A・事業提携・投資動向
    Cobham plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cobham plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Just the Berries Ltd:企業の戦略・SWOT・財務情報
    Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report Summary Just the Berries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆